BIT
BSTC

BlackRock Institutional Trust’s BioSpecifics Technologies Corp. BSTC Stock Holding History

BlackRock Institutional Trust’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.45M Buy
151,685
+11,192
+8% +$538K ﹤0.01% 2498
2016
Q3 		$6.42M Sell
140,493
-2,721
-2% -$109K ﹤0.01% 2588
2016
Q2 		$5.72M Buy
143,214
+12,600
+10% +$461K ﹤0.01% 2612
2016
Q1 		$4.55M Buy
130,614
+1,023
+0.8% +$37.5K ﹤0.01% 2711
2015
Q4 		$5.57M Sell
129,591
-26,135
-17% -$1.31M ﹤0.01% 2658
2015
Q3 		$6.78M Buy
155,726
+60,491
+64% +$3.26M ﹤0.01% 2540
2015
Q2 		$4.91M Buy
95,235
+2,473
+3% +$105K ﹤0.01% 2774
2015
Q1 		$3.63M Sell
92,762
-6,395
-6% -$251K ﹤0.01% 2864
2014
Q4 		$3.83M Buy
99,157
+18,996
+24% +$725K ﹤0.01% 2828
2014
Q3 		$2.83M Sell
80,161
-468
-0.6% -$13.7K ﹤0.01% 2921
2014
Q2 		$2.17M Buy
80,629
+8,616
+12% +$224K ﹤0.01% 3155
2014
Q1 		$1.87M Buy
72,013
+64,772
+895% +$1.55M ﹤0.01% 3190
2013
Q4 		$157K Buy
7,241
+4,834
+201% +$99K ﹤0.01% 3754
2013
Q3 		$47K Sell
2,407
-528
-18% -$9.36K ﹤0.01% 3823
2013
Q2 		$46K Buy
+2,935
New +$47.2K ﹤0.01% 3820

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

BlackRock Institutional Trust's BSTC Position: Q4 2016 in Review

BlackRock Institutional Trust increased its BioSpecifics Technologies Corp. (BSTC) stake by 8% in Q4 2016, buying an estimated $538K and bringing the position to 151,685 shares worth $8.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

BlackRock Institutional Trust first reported a position in BSTC in Q2 2013 and has held it in 15 quarters since. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

  • BlackRock Institutional Trust held 151,685 shares of BioSpecifics Technologies Corp. worth $8.45M as of Q4 2016.
  • BlackRock Institutional Trust bought 11,192 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $538K.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2498 holding.
  • BlackRock Institutional Trust first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 15 quarters since.
  • 96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.